Amkor Technology Inc.

▲ Bull Case

• ◆AI advanced packaging tripling in 2026 is partially de-risked and structurally durable. Q1 2026 beat (+27.5% YoY) with Computing +19% YoY validates ramp. Management's 'triple in 2026' guidance implies $1.2-1.5B annual run-rate vs. current $400-500M. Advanced Products at 82.8% of revenue are structurally less cyclical than mainstream. If ramp sustains into 2027-2028, justifies 12-14% sustainable operating margin vs. 7% trough.
• ◆#2 scale position + geographic diversification is becoming a competitive moat vs. TSMC and Chinese OSATs. ASE (Taiwan-concentrated) and JCET/Tongfu (China-dependent) face geopolitical risk. AMKR is only major OSAT with US HQ, new Arizona facility (CHIPS Act-eligible), and Vietnam presence. For US/allied customers (Apple, NVIDIA, AMD, Intel), AMKR's positioning offers 50-100 bps supply-chain security premium. Moat durable 3-5 years against TSMC and Chinese competitors.
• ◆Arizona facility + Vietnam ramp create 2027-2030 FCF upside not embedded in consensus. CHIPS Act ITC benefit of $700M-1.05B lifetime ($140-210M/year 2027-2030) hits FCF as capex converts post-2026. Consensus assumes neutral FCF impact; reality is $140-210M/year tax benefit. Vietnam productivity gains combined with marginal ROIC of 12-15% on incremental capex (well above WACC) support $5-10/share FCF upside to base case.

▼ Bear Case

• ◆TSMC vertical integration of AI advanced packaging (CoWoS expansion) could capture highest-end, highest-margin volume, leaving AMKR with second-source remainder. If TSMC expands internal capacity to 40-50% utilization and captures top-tier HBM/chiplet volume, AMKR loses 500-1,000 bps of volume. Results in -5-8% revenue impact (-$350-500M AI volume), 200-300 bps margin compression on remaining volume, stock downside to $55-65.
• ◆Customer concentration (Apple 29.8% + Qualcomm 11.1% = 40.9% of FY2025 revenue) creates binary revenue shock risk. Apple actively rotates volume and uses OSAT diversification as negotiating tactic. Realistic scenario: Apple reduces AMKR share from 30% to 25% of packaging needs. Impact: -$200-300M revenue (2-3% of total), 200-500 bps margin haircut on most profitable Advanced Products segment, stock downside to $60-70.
• ◆Semiconductor cyclical downturn in 2027-2028 would compress margins and capex, invalidating Arizona/Vietnam thesis timing. Realistic 10-15% revenue decline would compress gross margin to 12-13%, operating margin to 6-7%, force capex deferral ($200-300M), trigger 25-30% stock decline. Key risk: timing alignment — if AI ramp peaks H2 2026 just as broad semi cycle rolls, AMKR has no earnings cushion.

“Bull consensus (Needham $90 PT post-Q1 beat): AI advanced packaging is 5+ year structural growth driver; 'triple in 2026' is achievable and sustainable at 80-85% of revenue 2027-2028. Pricing discipline holds because AI demands premium packaging; TSMC internal capacity capped by overall CoWoS utilization. AMKR's geographic diversification is structural competitive advantage. Stock at $90 PT justifies 12-13% operating margins, 12-15% ROIC on incremental capex. Bear consensus (multiple strategists, PT $62.75): AI advanced packaging is cyclically elevated subject to TSMC displacement and customer concentration risks. Classic semiconductor downturn dynamics 2027-2028 likely. Through-cycle ROIC of 6-9% doesn't justify 48× forward P/E; stock priced for perfection. Analyst's read: Debate masks rate-of-change question. Consensus owns AI thesis; differentiated view is on durability. If Advanced Products reach 85-88% of revenue by 2028, company has de-risked from commodity mainstream. Bull wins if TSMC captures <30% of AI advanced packaging internally and semi cycle doesn't roll before AMKR de-risks. 2026-2027 catalyst calendar is high-information: Q2-Q4 2026 prints determine whether AI ramp is real or priced-in exuberance.”

• ◆Q2-Q3 2026 earnings (July-August): Computing segment revenue growth ≥15% YoY and gross margin ≥14.5% validates AI thesis; failure triggers trim to target. Catalyst magnitude ±$5-8/share. Highest-information catalyst.
• ◆FY2026 10-K filing (February 2027): Full-year revenue ≥$7.8B, operating margin ≥11%, AI advanced packaging confirmed >$1.0B annual run-rate confirms sustainability. Catalyst magnitude ±$8-12/share. Second-order validation of AI thesis.
• ◆Arizona facility capex progress (H2 2026-2027): Capex on track ($600-800M through 2027), advanced-packaging tools installed Q3 2026, customer commitments announced validates geographic diversification. Catalyst magnitude ±$3-5/share per quarter.
• ◆Vietnam facility productivity (2026-2027): Utilization >85%, yield rates align, cost per package <legacy by 5-10%, customers diversifying wafer inputs validates cost-diversification. Catalyst magnitude ±$2-3/share.
• ◆Customer diversification announcements (2026-2027): New customer AI wins (Broadcom, Marvell, SiFive) or Apple share maintenance addresses concentration risk. Catalyst magnitude ±$5-10/share.

• ◆TSMC Vertical Integration Acceleration (CRITICAL, 20-30% downside): TSMC expands CoWoS to 40-50% internal capacity, capturing top-tier HBM/chiplet volume. Impact: -5-8% revenue (-$350-500M AI volume), 200-300 bps margin compression. Probability 25-30%. Mitigation: Monitor TSMC capacity guidance; early signals in customer feedback.
• ◆Customer Concentration & Apple Rationalization (HIGH, 15-25% downside): Apple reduces AMKR share from 30% to 25% of packaging needs. Impact: -3-4% revenue (-$200-250M), 150-250 bps margin compression on highest-margin business. Probability 35-40%. Mitigation: Geographic/product diversification limits damage; Arizona appeals to Apple for US-content preference.
• ◆Semiconductor Cyclical Downturn 2027-2028 (HIGH, 25-35% downside): Broad-based supply/demand rebalancing triggers -10-15% revenue decline, 300-500 bps margin compression, capex deferral. Probability 30-40%. Mitigation: Advanced Products 85%+ mix cushions relative to mainstream; AI structural growth; capex flexibility.
• ◆Arizona Capex Execution Slippage (MEDIUM, 10-15% downside): Ramp delays into 2028, capital cost overruns, or CHIPS Act ITC benefit reduced. Impact: -$100-200M FCF over 2027-2030. Probability 20-25%. Mitigation: $700M net cash absorbs extension; Arizona is strategic investment justified by customer trust premium.
• ◆Foreign Exchange Headwind (MEDIUM, 5-10% impact): Weak USD or inability to pass through Asian cost inflation; 60-80% of COGS in Asia. Impact: 50-150 bps gross margin compression. Probability 50-60%. Mitigation: Natural hedge (US$ revenue, Asia-cost base); FX derivatives available.